Methods for treating vascular disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) C12N 9/64 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2284279

A method of treatment for patients with vascular occlusion and thromboembolic disorders including the acquired disease state of thrombotic stroke, by administering activated protein C. The administration of aPC provides a highly selective therapeutic agent with a low potential for causing bleeding complications. The administration of aPC is beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke.

L'invention porte sur un procédé de traitement de patients souffrant d'occlusion vasculaire ou de troubles thromboemboliques, y compris le stade acquis consécutif à une thrombose, par administration de protéine C activée. Ladite protéine est un agent thérapeutique très sélectif à faible potentiel de complications par saignement. Son administration prévient avantageusement l'extension locale des thrombus microvasculaires et macrovasculaires, et réduit de ce fait le déficit neurologique résultant de la thrombose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treating vascular disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating vascular disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating vascular disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1770345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.